Ipamorelin

Ipamorelin is a synthetic pentapeptide belonging to the growth hormone secretagogue class of experimental research peptides.

An important area of Ipamorelin research involves GHS-R1a (Growth Hormone Secretagogue Receptor 1a), also known as the ghrelin receptor. This receptor is associated with pituitary growth hormone release and multiple neuroendocrine signaling mechanisms.

In endocrine research, Ipamorelin is investigated in connection with pituitary GH release, pulsatile growth hormone secretion, and regulation of the GH/IGF-1 axis, providing a research tool for studying relationships between GHS-R1a activation and downstream endocrine responses.

Ipamorelin may also be compared experimentally with GHRP-6, GHRP-2, and GHRH-related analogs to investigate differences in receptor selectivity, cellular signaling, and endocrine responses among growth hormone secretagogues.

Additional research involves the ghrelin/GHS-R1a signaling system, energy homeostasis, metabolism, and hypothalamic-pituitary neuroendocrine mechanisms.

Ipamorelin remains an experimental research compound and is not an established anti-aging, muscle-building, or fat-loss medicine. Current research findings should not be interpreted as proven muscle-building, fat-loss, athletic-performance, or anti-aging effects in humans.

Livraison standard offerte dès 50 $ vers les États-Unis, le Canada, le Mexique et l'Europe. Expédition sous 1 jour ouvré.

Pas convaincu ? Renvoyez le produit sous 30 jours pour un remboursement intégral, même ouvert.